Microbot Medical, Inc. is a pre-clinical medical device company engaged in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The firm carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope, provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Hingham, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
20
Frequently Asked Questions
What is market cap of Microbot Medical Inc?
The market cap of Microbot Medical Inc is $18.23M
What is the 52 week high for Microbot Medical Inc?
The 52 week high for Microbot Medical Inc is $6.77.
What is the 52 week low for Microbot Medical Inc?
The 52 week low for Microbot Medical Inc is $2.12.
What is Microbot Medical Inc stock price today?
Microbot Medical Inc' stock price today is $2.32.
What is the pe ratio of Microbot Medical Inc?
The PE ratio of Microbot Medical Inc is -1.17.
What is the price to book ratio of Microbot Medical Inc?
The price to book ratio of Microbot Medical Inc is 2.9676.
What is Microbot Medical Inc's EBITDA?
Microbot Medical Inc's EBITDA is -14.053.
What is the 50-day moving average of Microbot Medical Inc?
The 50-day moving average of Microbot Medical Inc is 2.9538.